CBD Co. Zynerba, Investors Aim To Settle Drug Trial Claims

CBD Co. Zynerba, Investors Aim To Settle Drug Trial Claims CBD drugmaker Zynerba Pharmaceuticals and a proposed class of shareholders told a federal judge in Philadelphia that they expect to soon finalize details of a settlement that, if approved, will end claims that the company withheld adverse clinical trial results. #CBD #Hemp https://www.law360.com/cannabis/articles/1362663?utm_source=rss&utm_medium=rss&utm_campaign=section March 9, 2021 9:20 pm